Tommaso Mazzierli

Florence, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies.

Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies.

Journal: Journal of the American Society of Nephrology : JASN
Published: January 07, 2026

Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.

Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 25, 2025

A multidisciplinary model for implementation of nephrogenetics in CKD outpatients: a clinical and data-driven perspective.

A multidisciplinary model for implementation of nephrogenetics in CKD outpatients: a clinical and data-driven perspective.

Journal: Journal of nephrology
Published: August 02, 2025

Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.

Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 02, 2025

Urinary rituximab loss and rate of treatment failure in membranous nephropathy.

Urinary rituximab loss and rate of treatment failure in membranous nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: March 07, 2025

Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy.

Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy.

Journal: Kidney international reports
Published: March 01, 2025

Early identification of CKD in patients with solitary functioning kidney.

Early identification of CKD in patients with solitary functioning kidney.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: February 17, 2025

IgA Nephropathy With Membranoproliferative Pattern and Resistance to Immunosuppressive Therapy in Two Patients With Cofactor I Pathogenic Variant.

IgA Nephropathy With Membranoproliferative Pattern and Resistance to Immunosuppressive Therapy in Two Patients With Cofactor I Pathogenic Variant.

Journal: Nephrology (Carlton, Vic.)
Published: February 03, 2025

Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment-A Literature Review.

Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment-A Literature Review.

Journal: Journal of clinical medicine
Published: February 21, 2024

Correction to: Clinical features suggesting renal hypouricemia as the cause of acute kidney injury: a case report and review of the literature.

Correction to: Clinical features suggesting renal hypouricemia as the cause of acute kidney injury: a case report and review of the literature.

Journal: Journal of nephrology
Published: January 18, 2024

Severe proteinuria (but not being on dialysis) may be associated with initial inadequate complement inhibition and delayed hematological response to eculizumab therapy.

Severe proteinuria (but not being on dialysis) may be associated with initial inadequate complement inhibition and delayed hematological response to eculizumab therapy.

Journal: Journal of nephrology
Published: June 15, 2023

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management.

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management.

Journal: Frontiers in pharmacology
Published: November 11, 2022
Showing 1-12 of 15

Last Updated: 09/26/2026